Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia
Sponsor: Moogene Medi Co., Ltd
Summary
This is a randomized, open-label phase 1/2a study designed to evaluate the pharmacokinetics, pharmacodynamics, and safety of AD-303A (topical formulation) and AD-3031 in male patients with androgenetic alopecia. The study aims to compare pharmacological characteristics and safety profiles to support dose selection for further clinical development.
Official title: A Randomized, Open-label, Single and Multiple-dose, Parallel-design Phase 1/2a Clinical Trial to Evaluate the Pharmacokinetics/Pharmacodynamics and Safety of AD-303A and Oral Administration of AD-3031 in Male Androgenetic Alopecia Patients
Key Details
Gender
MALE
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-04
Completion Date
2026-12
Last Updated
2026-03-24
Healthy Volunteers
Yes
Conditions
Interventions
AD-303A
Topical AD-303A applied to the scalp according to the study protocol.
AD-3031
Oral AD-3031 administered according to the study protocol.
Locations (1)
Seoul National University Hospital
Seoul, Seoul, South Korea